Mitochondrial cytochrome P450 2E1 (CYP2E1), a potential direct source of ROS, has been shown to have an increased activity in a rodent model of NASH as well as in NASH patients [82,83]. The gene discussed is CYP2E1; the disease is metabolic dysfunction-associated steatohepatitis.